Table 4.
Summary results of PE outcomes: exposure-effects and dose-effects reported in individual cohort studies
‘Exposure-effects’* | ‘Dose-effects’† | |||||
---|---|---|---|---|---|---|
PE outcomes | Overall | BEI | Low | Med | High | Individual study results |
Abnormal PE: (# positive groups/# tested): | 46% (21/46) | 0% (0/7) | 40% (4/10) | 20% (2/10) | 79% (15/19) | 92% (12 of 13) |
| ||||||
Tremor: | 41% (19/46) | 0% | 30% | 10% | 79% | 83% (10 of 12) |
Motor Coordination: | 22% (10/46) | 0% | 10% | 10% | 42% | 80% (4 of 5) |
Deep Tendon Reflexes: | 22% (10/46) | 0% | 0% | 0% | 53% | 60% (3 of 5) |
Sensory Function: | 11% (05/46) | 0% | 0% | 0% | 26% | 75% (3 of 4) |
Key: Table presents summary results of all cohort studies that performed PE; data from the nested case-control study by Albers et al (1982) is not included.
= The proportion of cohort study groups with positive findings (i.e. # with ≥ 1 positive findings divided by # of study groups evaluated).
= The proportion of cohort studies that reported positive dose-relatedness among those cohort studies that evaluated dose-relatedness.